Log In

Missing trials in drug regulatory dossiers may have good reasons, but should be predefined and transparent

Files

1-s2.0-S0895435621003504-main.pdf (232.73 KB)

Publication date

2022-02

Authors

Leufkens, H.G.ISNI 0000000392454327

Editors

Advisors

Supervisors

DOI

https://doi.org/10.1016/j.jclinepi.2021.10.026

Document Type

Comment

Metadata

Show full item record

Collections

Utrecht University Repository
Open Access logo

License

cc_by

Abstract

Keywords

Epidemiology

Citation

Leufkens, H G 2022, 'Missing trials in drug regulatory dossiers may have good reasons, but should be predefined and transparent', Journal of Clinical Epidemiology, vol. 142, pp. 258-260. https://doi.org/10.1016/j.jclinepi.2021.10.026

URI

http://hdl.handle.net/1874/452284